Avenue Therapeutics Inc (NASDAQ:ATXI)

1.81
Delayed Data
As of Jul 29
 -0.06 / -3.17%
Today’s Change
1.75
Today|||52-Week Range
12.34
-69.58%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Major
MARKET CAP
$33.0M

Company Description

Avenue Therapeutics, Inc. is a specialty pharmaceutical company, which engages in acquiring, licensing, and commercializing products for use in the intensive care hospital setting. It focuses on the development of intravenous tramadol, a potential alternative that could reduce the use of conventional opioids for patients suffering from acute pain. The company was founded on February 9, 2015 and is headquartered in New York, NY.

Contact Information

Avenue Therapeutics, Inc.
1140 Avenue of the Americas
New York New York 10036
P:(781) 652-4500
Investor Relations:

Employees

Shareholders

Other institutional7.03%
Individual stakeholders59.91%
Mutual fund holders4.19%

Top Executives

Lucy LuPresident, Chief Executive Officer & Director
Joseph VazzanoChief Financial Officer & Secretary
Scott A. ReinesChief Medical Officer